Logiscreen

Jazz Pharmaceuticals plc

$238.57
Market Cap 14.69B
ROE 0.7%
Gross Margin 87.5%
Debt/Equity 1.2
Current Ratio 2.0
Revenue QoQ 19.1%
EPS QoQ -4.1%
F-Score 7

About

Jazz Pharmaceuticals plc is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with rare disease — often with limited or no therapeutic options. We have a diverse portfolio of medicines, including leading therapies addressing epilepsies, cancers and sleep disorders. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide.

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology

Sector context

Healthcare

Overvalued

Trading at a discount to sector peers

P/E
501.07
vs median 33.61
P/B
3.26
vs median 2.16
ROE
0.01
vs median 0.09

High quality company with strong fundamentals

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics